{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:20:41Z","timestamp":1791764441359,"version":"4.3.4"},"reference-count":122,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Cancer Research Association","award":["IG24851"],"award-info":[{"award-number":["IG24851"]}]},{"name":"Italian Ministry of University and Research","award":["2022BFF2CJ"],"award-info":[{"award-number":["2022BFF2CJ"]}]},{"name":"National Center for Gene Therapy and Drugs based on RNA Technology, Spoke2","award":["M4C2-Investimento 1.4-CN00000041-VP"],"award-info":[{"award-number":["M4C2-Investimento 1.4-CN00000041-VP"]}]},{"name":"Italian Cancer Research Foundation (FIRC) post-doctoral fellowship","award":["31186"],"award-info":[{"award-number":["31186"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Signal transducer and activator of transcription 3 (STAT3) is a central oncogenic hub in several tumors including the Triple-Negative Breast Cancer (TNBC) subtype, where its constitutive activity supports proliferation, metabolic flexibility, tumor progression, immune evasion, and therapeutic resistance. Therapeutic development has largely focused on canonical STAT3 activation driven by tyrosine 705 phosphorylation (p-Y705), which enables dimerization and transcriptional programs. However, accumulating evidence indicates that phosphorylation at serine 727 (p-S727) defines a functionally distinct STAT3 axis, underpinning non-canonical activities across extranuclear compartments that include mitochondria and endoplasmic reticulum\/mitochondria-associated membranes. In TNBC, p-S727 STAT3 is frequently prevalent and may sustain oncogenic signaling when p-Y705 is low or pharmacologically suppressed, contributing to metabolic rewiring, redox control, apoptosis resistance, and metastatic fitness. Here, we review the mechanistic basis and clinical correlations of STAT3 p-S727 across cancers with emphasis on TNBC, and discuss how compartmentalized STAT3 pools may integrate kinase signaling, nutrient sensing, and stress responses. We also summarize emerging therapeutic strategies that modulate p-S727\u2014often in conjunction with p-Y705\u2014highlighting proof-of-concept for dual targeting or specific p-S727 to overcome limitations of Y705-centric approaches. Finally, we propose that integrating p-S727\/p-Y705 distribution and activity into patient stratification could improve the efficacy\u2013toxicity balance of STAT3-directed therapies in TNBC.<\/jats:p>","DOI":"10.3390\/ijms27052242","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:38Z","timestamp":1772207558000},"page":"2242","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Out of Nucleus: Serine 727 Phosphorylation Orchestrates Non-Canonical STAT3 Functions\u2014Relevance to Triple-Negative Breast Cancer"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-3986","authenticated-orcid":false,"given":"Daniele","family":"Viavattene","sequence":"first","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Via Nizza 52, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-2706","authenticated-orcid":false,"given":"Andrea Roberto","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Via Nizza 52, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0770-741X","authenticated-orcid":false,"given":"Nicole","family":"Schael","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Via Nizza 52, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-3966","authenticated-orcid":false,"given":"Valeria","family":"Poli","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Via Nizza 52, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: From interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: Negative regulators of cytokine signaling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cells"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.2741\/3051","article-title":"Protein tyrosine phosphatases in the JAK\/STAT pathway","volume":"13","author":"Xu","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: Transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","article-title":"STAT3 in cancer: A double edged sword","volume":"98","author":"Avalle","year":"2017","journal-title":"Cytokine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2021). The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020603"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1073\/pnas.0604042103","article-title":"STAT3: A multifaceted oncogene","volume":"103","author":"Levy","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/ijc.28767","article-title":"STAT3 and metabolism: How many ways to use a single molecule?","volume":"135","author":"Demaria","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/cdd.2012.20","article-title":"STAT3 can serve as a hit in the process of malignant transformation of primary cells","volume":"19","author":"Demaria","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2013-02-484196","article-title":"STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation","volume":"124","author":"Gough","year":"2014","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj3470089","article-title":"Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1\/MKK-4 as signal transduction components","volume":"347","author":"Schuringa","year":"2000","journal-title":"Biochem. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41388-021-02134-4","article-title":"Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer","volume":"41","author":"Alhayyani","year":"2022","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","article-title":"Unraveling the complexity of STAT3 in cancer: Molecular understanding and drug discovery","volume":"43","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1126\/science.1164551","article-title":"Function of mitochondrial Stat3 in cellular respiration","volume":"323","author":"Wegrzyn","year":"2009","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Avalle, L., and Poli, V. (2018). Nucleus, Mitochondrion, or Reticulum? STAT3 \u00e0 La Carte. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092820"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41418-018-0171-y","article-title":"STAT3 localizes to the ER, acting as a gatekeeper for ER-mitochondrion Ca2+ fluxes and apoptotic responses","volume":"26","author":"Avalle","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Su, Y., Huang, X., Huang, Z., Huang, T., Xu, Y., and Yi, C. (2020). STAT3 Localizes in Mitochondria-Associated ER Membranes Instead of in Mitochondria. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00274"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","article-title":"Serine phosphorylation of STATs","volume":"19","author":"Decker","year":"2000","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MCB.24.1.407-419.2004","article-title":"Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation","volume":"24","author":"Shen","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yang, P.L., Liu, L.X., Li, E.M., and Xu, L.Y. (2020). STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy. Cancers, 12.","DOI":"10.3390\/cancers12092459"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31280","DOI":"10.1074\/jbc.M113.505057","article-title":"Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-12-0194","article-title":"p42\/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth","volume":"20","author":"Tkach","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1128\/MCB.17.11.6508","article-title":"STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation","volume":"17","author":"Chung","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tesoriere, A., Dinarello, A., and Argenton, F. (2021). The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080956"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1158\/0008-5472.CAN-08-1125","article-title":"Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation","volume":"68","author":"Qin","year":"2008","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41419-022-05456-7","article-title":"Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/0008-5472.CAN-09-2840","article-title":"Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten","volume":"70","author":"Barbieri","year":"2010","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: A systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: Where is the Achilles\u2019 heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41401-021-00718-0","article-title":"The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts","volume":"43","author":"Zhong","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114053","DOI":"10.1016\/j.bcp.2020.114053","article-title":"A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction","volume":"178","author":"Park","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e25124","DOI":"10.1097\/MD.0000000000025124","article-title":"p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/ijc.21771","article-title":"STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma","volume":"118","author":"Yeh","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.prp.2018.12.023","article-title":"pSTAT3 expression associated with survival and mammographic density of breast cancer patients","volume":"215","author":"Radenkovic","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1610592","DOI":"10.3389\/pore.2022.1610592","article-title":"Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer","volume":"28","author":"Stenckova","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112313","DOI":"10.1016\/j.yexcr.2020.112313","article-title":"Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer","volume":"396","author":"Dimri","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/MCB.18.5.2553","article-title":"Stat3 activation is required for cellular transformation by v-src","volume":"18","author":"Bromberg","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"ref_44","first-page":"65","article-title":"STAT1 and STAT3 in tumorigenesis: A matter of balance","volume":"1","author":"Avalle","year":"2012","journal-title":"Jakstat"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: New and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.18632\/aging.100232","article-title":"A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction","volume":"2","author":"Demaria","year":"2010","journal-title":"Aging"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Hughes, K., and Watson, C.J. (2018). The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061695"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41388-021-02172-y","article-title":"STAT3 induces breast cancer growth via ANGPTL4, MMP13 and STC1 secretion by cancer associated fibroblasts","volume":"41","author":"Avalle","year":"2022","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13058-025-02074-x","article-title":"Cancer-associated fibroblast driven paracrine IL-6\/STAT3 signaling promotes migration and dissemination in invasive lobular carcinoma","volume":"27","author":"Bullock","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"189461","DOI":"10.1016\/j.bbcan.2025.189461","article-title":"STAT3 axis in cancer and cancer stem cells: From oncogenesis to targeted therapies","volume":"1880","author":"Godugu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wei, S., Li, J., Tang, M., Zhang, K., Gao, X., Fang, L., and Liu, W. (2022). STAT3 and p63 in the Regulation of Cancer Stemness. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.909251"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11658-018-0078-0","article-title":"STAT3, stem cells, cancer stem cells and p63","volume":"23","author":"Galoczova","year":"2018","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nm976","article-title":"Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells","volume":"10","author":"Wang","year":"2004","journal-title":"Nat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.0900473106","article-title":"Genome-wide discovery of functional transcription factor binding sites by comparative genomics: The case of Stat3","volume":"106","author":"Vallania","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"106357","DOI":"10.1016\/j.phrs.2022.106357","article-title":"Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action","volume":"182","author":"Yang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Berkley, K., Zalejski, J., and Sharma, A. (2025). Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?. Cancers, 17.","DOI":"10.20944\/preprints202501.1371.v1"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation","volume":"82","author":"Wen","year":"1995","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M112.378984","article-title":"The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain","volume":"288","author":"Tammineni","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_61","first-page":"1","article-title":"Structural determinants of mitochondrial STAT3 targeting and function","volume":"2","author":"Lahiri","year":"2024","journal-title":"Mitochondrial Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"dev199477","DOI":"10.1242\/dev.199477","article-title":"Y705 and S727 are required for the mitochondrial import and transcriptional activities of STAT3, and for regulation of stem cell proliferation","volume":"148","author":"Peron","year":"2021","journal-title":"Development"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"618","DOI":"10.15252\/embj.201592629","article-title":"Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency","volume":"35","author":"Carbognin","year":"2016","journal-title":"EMBO J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0960-9822(99)00268-7","article-title":"Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR","volume":"10","author":"Yokogami","year":"2000","journal-title":"Curr. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19552","DOI":"10.1038\/s41598-023-46628-5","article-title":"STAT3 phosphorylation at serine 727 activates specific genetic programs and promotes clear cell renal cell carcinoma (ccRCC) aggressiveness","volume":"13","author":"Arevalo","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12935-024-03541-9","article-title":"STAT3: Key targets of growth-promoting receptor positive breast cancer","volume":"24","author":"Jiang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"23532","DOI":"10.1074\/jbc.C110.152652","article-title":"Stoichiometry of STAT3 and mitochondrial proteins: Implications for the regulation of oxidative phosphorylation by protein-protein interactions","volume":"285","author":"Phillips","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"39517","DOI":"10.1038\/srep39517","article-title":"STAT3 Undergoes Acetylation-dependent Mitochondrial Translocation to Regulate Pyruvate Metabolism","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"eaag2588","DOI":"10.1126\/scisignal.aag2588","article-title":"Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production","volume":"10","author":"Meier","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/1878-0261.12928","article-title":"Mitochondrial STAT3 regulates antioxidant gene expression through complex I-derived NAD in triple negative breast cancer","volume":"15","author":"Lahiri","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"40892","DOI":"10.1074\/jbc.M506623200","article-title":"The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria","volume":"280","author":"Mendes","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102759","DOI":"10.1016\/j.ceca.2023.102759","article-title":"Ca2+ signaling and cell death","volume":"113","author":"Dhaouadi","year":"2023","journal-title":"Cell Calcium"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2012.09.013","article-title":"Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity","volume":"48","author":"Shen","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41422-018-0080-0","article-title":"STAT3 associates with vacuolar H+-ATPase and regulates cytosolic and lysosomal pH","volume":"28","author":"Liu","year":"2018","journal-title":"Cell Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"112137","DOI":"10.1016\/j.celrep.2023.112137","article-title":"Cationic amphiphilic antihistamines inhibit STAT3 via Ca2+-dependent lysosomal H+ efflux","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1038\/s41467-018-07741-6","article-title":"Lysosomal protease deficiency or substrate overload induces an oxidative-stress mediated STAT3-dependent pathway of lysosomal homeostasis","volume":"9","author":"Prescott","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ncb2171","article-title":"Stat3 controls lysosomal-mediated cell death in vivo","volume":"13","author":"Kreuzaler","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ncb3043","article-title":"Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization","volume":"16","author":"Sargeant","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"189207","DOI":"10.1016\/j.bbcan.2024.189207","article-title":"Structure, function, signaling pathways and clinical therapeutics: The translational potential of STAT3 as a target for cancer therapy","volume":"1879","author":"Shi","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pros.24820","article-title":"pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy","volume":"85","author":"Bialas","year":"2025","journal-title":"Prostate"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"42560","DOI":"10.18632\/oncotarget.17245","article-title":"Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score","volume":"8","author":"Cocchiola","year":"2017","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"E975","DOI":"10.1152\/ajpendo.00615.2012","article-title":"Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser727 on STAT3 in prostate cancer cells","volume":"305","author":"Hsu","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"17307","DOI":"10.1038\/s41598-018-35612-z","article-title":"Galiellalactone inhibits the STAT3\/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer","volume":"8","author":"Thaper","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2005.05.032","article-title":"The role of p-STAT3 (ser727) revealed by its association with Ki-67 in cervical intraepithelial neoplasia","volume":"98","author":"Yang","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ygyno.2014.07.087","article-title":"Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor","volume":"135","author":"Tierney","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/jid.2012.45","article-title":"Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells","volume":"132","author":"Sakaguchi","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/0008-5472.CAN-13-1671","article-title":"HAVCR\/KIM-1 activates the IL-6\/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome","volume":"74","author":"Cuadros","year":"2014","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1038\/s41598-021-86218-x","article-title":"Nuclear and cytosolic pS727-STAT3 levels correlate with overall survival of patients affected by clear cell renal cell carcinoma (ccRCC)","volume":"11","author":"Arevalo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12254","article-title":"STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma","volume":"26","author":"Kemeny","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_91","first-page":"3141","article-title":"STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma","volume":"7","author":"Lin","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ol.2010.210","article-title":"Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells","volume":"2","author":"Lee","year":"2011","journal-title":"Oncol. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells","volume":"115","author":"Harris","year":"2010","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Naik, A., Thomas, R., Sikhondze, M., Babiker, A., Lattab, B., Qasem, H., Jafar, U., and Decock, J. (2024). The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival. Cancers, 16.","DOI":"10.3390\/cancers16132451"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/1878-0261.13024","article-title":"Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy","volume":"16","author":"Naik","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41523-020-0157-z","article-title":"BCL9\/STAT3 regulation of transcriptional enhancer networks promote DCIS progression","volume":"6","author":"Elsarraj","year":"2020","journal-title":"npj Breast Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"94591","DOI":"10.18632\/oncotarget.21813","article-title":"C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells","volume":"8","author":"Shin","year":"2017","journal-title":"Oncotarget"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Mackenzie, G.G., Huang, L., Alston, N., Ouyang, N., Vrankova, K., Mattheolabakis, G., Constantinides, P.P., and Rigas, B. (2013). Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061532"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","article-title":"Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion","volume":"105","author":"Boengler","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2019.04.024","article-title":"Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors","volume":"174","author":"Cai","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"101822","DOI":"10.1016\/j.isci.2020.101822","article-title":"STAT3 Inhibitor OPB-51602 Is Cytotoxic to Tumor Cells Through Inhibition of Complex I and ROS Induction","volume":"23","author":"Brambilla","year":"2020","journal-title":"iScience"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"E4924","DOI":"10.1073\/pnas.1615730114","article-title":"Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells","volume":"114","author":"Genini","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.molonc.2015.02.012","article-title":"Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)","volume":"9","author":"Brambilla","year":"2015","journal-title":"Mol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00280-014-2480-2","article-title":"Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors","volume":"74","author":"Bendell","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/bph.17460","article-title":"Sculponeatin A induces mitochondrial dysfunction in non-small cell lung cancer through WWP2-mediated degradation of mitochondrial STAT3","volume":"182","author":"Wan","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"154921","DOI":"10.1016\/j.phymed.2023.154921","article-title":"Sculponeatin A promotes the ETS1-SYVN1 interaction to induce SLC7A11\/xCT-dependent ferroptosis in breast cancer","volume":"117","author":"Peng","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: A new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"113333","DOI":"10.1016\/j.ejmech.2021.113333","article-title":"Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors","volume":"216","author":"Gao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10549-022-06790-2","article-title":"Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis","volume":"197","author":"Yang","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1111\/bph.70071","article-title":"A novel synthesised STAT3 inhibitor exerts potent anti-tumour activity by inducing lysosome-dependent cell death","volume":"182","author":"Xu","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/acscentsci.3c01440","article-title":"Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment","volume":"10","author":"Chen","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.12659\/MSM.918384","article-title":"Napabucasin Attenuates Resistance of Breast Cancer Cells to Tamoxifen by Reducing Stem Cell-Like Properties","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1021\/acs.jmedchem.2c00413","article-title":"Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705\/Ser727 Inhibitory Activity for Gastric Cancer Treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1021\/acs.jmedchem.2c01554","article-title":"Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"157485","DOI":"10.1016\/j.phymed.2025.157485","article-title":"Pulchinenoside E2: A dual-functional STAT3 and autophagy inhibitor with potent anti-metastatic activity in triple-negative breast cancer","volume":"148","author":"Zheng","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1535-7163.MCT-20-0599","article-title":"Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides","volume":"20","author":"Shiah","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"314ra185","DOI":"10.1126\/scitranslmed.aac5272","article-title":"AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer","volume":"7","author":"Hong","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e2523039122","DOI":"10.1073\/pnas.2523039122","article-title":"A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance","volume":"122","author":"Liaki","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e160606","DOI":"10.1172\/jci.insight.160606","article-title":"Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer","volume":"7","author":"Jin","year":"2022","journal-title":"JCI Insight"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Li, H., Wang, L., Cao, F., Yu, D., Yang, J., Yu, X., Dong, J., Qin, J.J., and Guan, X. (2022). Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.944455"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2242\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:54:08Z","timestamp":1772207648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":122,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27052242"],"URL":"https:\/\/doi.org\/10.3390\/ijms27052242","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}